XML 23 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income $ 39,526,000 $ 33,526,000 $ 31,931,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 6,477,000 6,177,000 5,958,000
Net amortization of premiums on securities 2,456,000 3,298,000 3,192,000
Provision for loan losses 8,934,000 13,361,000 9,638,000
Share-based compensation 1,301,000 1,174,000 845,000
Deferred income tax (benefit) expense (10,480,000) 12,403,000 (1,718,000)
Proceeds from sale of loans held for sale 30,547,000 14,555,000 11,655,000
Originations of loans held for sale (29,901,000) (15,847,000) (11,035,000)
Increase in company owned life insurance (1,793,000) (1,781,000) (2,808,000)
Net gain on sale of loans held for sale (796,000) (376,000) (240,000)
Net loss (gain) on investment securities 127,000 (1,260,000) (2,695,000)
Goodwill impairment 2,350,000 1,575,000 0
Net gain on other assets (50,000) (37,000) (313,000)
Decrease (increase) in other assets 13,376,000 (24,505,000) 2,027,000
Increase in other liabilities 3,065,000 4,016,000 257,000
Net cash provided by operating activities 65,139,000 46,279,000 46,694,000
Cash flows from investing activities:      
Purchases of available for sale securities (44,919,000) (86,434,000) (213,413,000)
Purchases of held to maturity securities (28,017,000) (71,479,000) (126,375,000)
Proceeds from principal payments, maturities and calls on available for sale securities 90,114,000 51,978,000 119,190,000
Proceeds from principal payments, maturities and calls on held to maturity securities 96,211,000 96,376,000 66,579,000
Proceeds from sales of securities available for sale 29,851,000 50,084,000 95,261,000
Net loan originations (361,915,000) (404,905,000) (262,684,000)
Purchases of company owned life insurance, net of benefits received (35,000) (52,000) 2,398,000
Proceeds from sales of other assets 590,000 234,000 854,000
Purchases of premises and equipment (2,842,000) (7,740,000) (7,619,000)
Cash consideration paid for acquisition, net of cash acquired (4,447,000) (676,000) (868,000)
Net cash used in investing activities (225,409,000) (372,614,000) (326,677,000)
Cash flows from financing activities:      
Net increase in deposits 156,733,000 214,952,000 264,691,000
Net increase in short-term borrowings 23,300,000 114,700,000 38,400,000
Repurchase of preferred stock (1,000) (9,000)  
Proceeds from issuance of common stock   38,303,000  
Purchases of common stock for treasury (113,000) (148,000)  
Proceeds from stock options exercised 320,000 413,000 964,000
Excess tax benefit on share-based compensation     30,000
Cash dividends paid to preferred shareholders (1,462,000) (1,462,000) (1,462,000)
Cash dividends paid to common shareholders (14,947,000) (12,496,000) (11,484,000)
Net cash provided by financing activities 163,830,000 354,253,000 291,139,000
Net increase in cash and cash equivalents 3,560,000 27,918,000 11,156,000
Cash and cash equivalents, beginning of period 99,195,000 71,277,000 60,121,000
Cash and cash equivalents, end of period $ 102,755,000 $ 99,195,000 $ 71,277,000